AIP/ARDS	Acute Interstitial Pneumonia/Acute Respiratory Distress Syndrome
ALT	Alanine Transaminase
ASCO	American Society of Clinical Oncology
AST	Aspartate aminotransferase
COP	Cryptogenic Organizing Pneumonia
CT	Computed Tomography
CTCAE	Common Terminology Criteria for Adverse Events
CTLA-4	Cytotoxic T-Lymphocyte–Associated Antigen 4
EMA	European Medicines Agency
ESMO	European Society for Medical Oncology
FDG-PET	Fluorodeoxyglucose-Positron Emission Tomography
FT4	Free Thyroxine
HP	Hypersensitivity Pneumonitis
HRT	Hormone Replacement Therapy
ICIs	Immunotherapy with Checkpoint Inhibitors
irAEs	immune-related Adverse Events
MRI	Magnetic Resonance Imaging
NCCN	National Comprehensive Cancer Network
NCI-CTCAE	National Cancer Institute - Common Terminology Criteria for Adverse Events
NSIP	Non-Specific Interstitial Pneumonia
PD-1	Programmed Death 1
PD-L1	Programmed Death-Ligand 1
RR	Relative Risk
SCAD	Segmental Colitis Associated with Diverticulosis
TSH	Thyroid-Stimulating Hormone
U.S. FDA	United States Food and Drug Administration
US	Ultrasound